NCT00197678View on ClinicalTrials.gov

Multivitamin Dosage Regimens in the Prevention of Adverse Pregnancy Outcomes Among HIV-Positive Women

PHASE3CompletedINTERVENTIONAL
Enrollment

1,141

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions
HIV Infections
Interventions
DIETARY_SUPPLEMENT

Multivitamins-Multiples of RDA

20 mg B1, 20 mg B2, 25 mg B6, 50 mcg B12, 100 mg niacin, 500 mg C, 30 mg E, 0.8 mg folic acid taken orally once per day until 6 weeks after delivery

DIETARY_SUPPLEMENT

Multivitamins-Single RDA

1.4 mg B1, 1.4 mg B2, 1.9 mg B6, 50 mcg B12, 100 mg niacin, 70 mg C, 10 mg E, and 0.4 mg folic acid taken orally once per day until 6 weeks after delivery

Trial Locations (1)

02115

Harvard School of Public Health, Boston

All Listed Sponsors
collaborator

Muhimbili University of Health and Allied Sciences

OTHER

lead

Harvard School of Public Health (HSPH)

OTHER

NCT00197678 - Multivitamin Dosage Regimens in the Prevention of Adverse Pregnancy Outcomes Among HIV-Positive Women | Biotech Hunter | Biotech Hunter